Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1969 2
1970 2
1971 3
1972 2
1973 1
1974 1
1976 1
1978 2
1979 1
1981 1
1982 1
1983 1
1984 3
1985 3
1986 2
1987 11
1988 8
1989 7
1990 11
1991 3
1992 7
1993 7
1994 6
1995 7
1996 11
1997 5
1998 11
1999 18
2000 12
2001 15
2002 10
2003 25
2004 18
2005 18
2006 14
2007 13
2008 15
2009 17
2010 15
2011 17
2012 22
2013 30
2014 29
2015 46
2016 32
2017 43
2018 66
2019 44
2020 53
2021 58
2022 67
2023 93
2024 27

Text availability

Article attribute

Article type

Publication date

Search Results

853 results

Results by year

Filters applied: . Clear all
Page 1
Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.
Sterkens A, Lambert J, Bervoets A. Sterkens A, et al. Clin Exp Med. 2021 May;21(2):215-230. doi: 10.1007/s10238-020-00673-w. Epub 2021 Jan 1. Clin Exp Med. 2021. PMID: 33386567 Review.
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebrows, or even the entire body. ...The prognosis is uncertain and is negatively influenced by the subtypes alopecia totalis and alop
Patients suffering from alopecia areata (AA) can lose hair in focal regions, the complete scalp, including eyelashes and eyebr …
Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
Zhou C, Li X, Wang C, Zhang J. Zhou C, et al. Clin Rev Allergy Immunol. 2021 Dec;61(3):403-423. doi: 10.1007/s12016-021-08883-0. Epub 2021 Aug 17. Clin Rev Allergy Immunol. 2021. PMID: 34403083 Review.
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in hair loss, that affects up to 2% of the general population. ...There are several clinical treatments for AA, varying from one or multiple well-defined patches to more diffuse o
Alopecia areata (AA) is a common chronic tissue-specific autoimmune disease, resulting in hair loss, that affects up to 2% of
Treatment of pediatric alopecia areata: A systematic review.
Barton VR, Toussi A, Awasthi S, Kiuru M. Barton VR, et al. J Am Acad Dermatol. 2022 Jun;86(6):1318-1334. doi: 10.1016/j.jaad.2021.04.077. Epub 2021 Apr 30. J Am Acad Dermatol. 2022. PMID: 33940103 Free PMC article. Review.
BACKGROUND: Alopecia areata (AA) is an autoimmune, nonscarring hair loss disorder with slightly greater prevalence in children than adults. ...
BACKGROUND: Alopecia areata (AA) is an autoimmune, nonscarring hair loss disorder with slightly greater prevalence in children …
Alopecia areata.
Pratt CH, King LE Jr, Messenger AG, Christiano AM, Sundberg JP. Pratt CH, et al. Nat Rev Dis Primers. 2017 Mar 16;3:17011. doi: 10.1038/nrdp.2017.11. Nat Rev Dis Primers. 2017. PMID: 28300084 Free PMC article. Review.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. ...A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata. Genetic
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair foll
Biomarkers in alopecia Areata: A systematic review and meta-analysis.
Zaaroura H, Gilding AJ, Sibbald C. Zaaroura H, et al. Autoimmun Rev. 2023 Jul;22(7):103339. doi: 10.1016/j.autrev.2023.103339. Epub 2023 Apr 20. Autoimmun Rev. 2023. PMID: 37087083 Review.
BACKGROUND: Alopecia areata (AA) is an autoimmune non-scarring alopecia that affects the scalp or any hair-bearing areas in the body. ...
BACKGROUND: Alopecia areata (AA) is an autoimmune non-scarring alopecia that affects the scalp or any hair-bearing area …
Alopecia Areata. Current situation and perspectives.
Juárez-Rendón KJ, Rivera Sánchez G, Reyes-López MÁ, García-Ortiz JE, Bocanegra-García V, Guardiola-Avila I, Altamirano-García ML. Juárez-Rendón KJ, et al. Arch Argent Pediatr. 2017 Dec 1;115(6):e404-e411. doi: 10.5546/aap.2017.eng.e404. Arch Argent Pediatr. 2017. PMID: 29087123 Free article. Review. English, Spanish.
Alopecia areata (AA) is a dermatological disease characterized by non-scarring hair loss of the scalp and/or body, with an unpredictable and variable evolution in the patients in which, despite multidisciplinary efforts, its etiology is not entirely known, although
Alopecia areata (AA) is a dermatological disease characterized by non-scarring hair loss of the scalp and/or body, with an unp
Alopecia Areata: Current Treatments and New Directions.
Dahabreh D, Jung S, Renert-Yuval Y, Bar J, Del Duca E, Guttman-Yassky E. Dahabreh D, et al. Am J Clin Dermatol. 2023 Nov;24(6):895-912. doi: 10.1007/s40257-023-00808-1. Epub 2023 Aug 22. Am J Clin Dermatol. 2023. PMID: 37606849 Review.
Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at the hair follicle level. ...Given the recent US FDA approval of baricitinib and ritlecitinib, Janus kinase (JAK) inhibitors are a promising drug c
Alopecia areata is an autoimmune hair loss disease that is non-scarring and is characterized by chronic inflammation at the ha
Systematic review of newer agents for the management of alopecia areata in adults: Janus kinase inhibitors, biologics and phosphodiesterase-4 inhibitors.
Gupta AK, Wang T, Polla Ravi S, Bamimore MA, Piguet V, Tosti A. Gupta AK, et al. J Eur Acad Dermatol Venereol. 2023 Apr;37(4):666-679. doi: 10.1111/jdv.18810. Epub 2022 Dec 22. J Eur Acad Dermatol Venereol. 2023. PMID: 36478475 Review.
Management options for moderate-to-severe alopecia areata (AA) are limited owing to a lack of safe and effective treatments suitable for long-term use. ...In this article, we conducted a systematic review of newer agents, including Janus kinase (JAK) inhibitors, bio …
Management options for moderate-to-severe alopecia areata (AA) are limited owing to a lack of safe and effective treatments su …
Common causes of hair loss - clinical manifestations, trichoscopy and therapy.
Alessandrini A, Bruni F, Piraccini BM, Starace M. Alessandrini A, et al. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):629-640. doi: 10.1111/jdv.17079. Epub 2021 Jan 8. J Eur Acad Dermatol Venereol. 2021. PMID: 33290611 Review.
The most important hair diseases are divided in non- cicatricial and cicatricial ones. Non-cicatricial alopecia are more frequent than cicatricial alopecia. The first step is to obtain a good history and physical examination. Laboratory testing is often unnecessary, …
The most important hair diseases are divided in non- cicatricial and cicatricial ones. Non-cicatricial alopecia are more frequent tha …
Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Strazzulla LC, et al. J Am Acad Dermatol. 2018 Jan;78(1):1-12. doi: 10.1016/j.jaad.2017.04.1141. J Am Acad Dermatol. 2018. PMID: 29241771 Review.
Alopecia areata (AA) is a common, inflammatory, nonscarring type of hair loss. ...
Alopecia areata (AA) is a common, inflammatory, nonscarring type of hair loss. ...
853 results